eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2012
vol. 7
 
Share:
Send email
Share:
abstract:
Review paper

Treatment prospects of Helicobacter pylori infection

Dorota Ksiądzyna
,
Marta Szandruk
,
Adam Szeląg

Przegląd Gastroenterologiczny 2012; 7 (2): 70–77
DOI: https://doi.org/10.5114/pg.2012.28647
Online publish date: 2012/05/22
View full text Get citation
 
PlumX metrics:
In the near future treatment of Helicobacter pylori (H. pylori) infection may be problematic because of the growing resistance of this microorganism to antibacterial drugs included in the eradication scheme. Standard therapy is inefficacious in as many as 25% of cases, and currently available second- and third-line schemes are inefficacious in approximately 20% of patients. These observations lead to numerous trials that assess applicability of alternative antibiotics/chemotherapeutics, novel substances inhibiting H. pylori growth, and research on new patterns of eradication. In order to improve the healing effectiveness and to decrease the risk of adverse effects, not only appropriate drug selection but also optimal dosage and duration of treatment are essential. This paper presents a review of research results and clinical trials aimed at invention of the best eradication pattern, especially in case of failure of the standard therapy.
keywords:

Helicobacter pylori infection, antibiotic treatment, eradication
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.